2.213 Improved antiparkinsonian effects during the night with levodopa/dopa decarboxylase inhibitor and entacapone compared with levodopa/dopa decarboxylase inhibitor in Parkinson's disease patients experiencing symptom re-emergence due to wearing-off

Autor:	Nissinen, H., Kuoppamäki, M., Leinonen, M.
Zdroj:	In Parkinsonism and Related Disorders 2007 13 Supplement 2:S101-S101
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect